BioLife Solutions Inc. (BLFS) is a publicly traded Healthcare sector company. As of July 22, 2026, BLFS trades at $29.75 with a market cap of $1.42B and a P/E ratio of -323.73. BLFS moved +1.90% today. Year to date, BLFS is +20.72%; over the trailing twelve months it is +40.61%. Its 52-week range spans $17.86 to $30.88. Analyst consensus is strong buy with an average price target of $33.00. Rallies surfaces BLFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover BLFS: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $33.00.
| Metric | Value |
|---|---|
| Price | $29.75 |
| Market Cap | $1.42B |
| P/E Ratio | -323.73 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.88 |
| 52-Week Low | $17.86 |
| Volume | 1.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $96.21M |
| Net Income | $-4.59M |
| Gross Margin | 64.56% |
5 analysts cover BLFS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $33.00.